IQVIA (IQV) President Granted Stock Appreciation Rights
IQVIA HOLDINGS INC.
Subscribe to track IQV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
IQVIA (IQV) President Granted Stock Appreciation Rights
Company: IQVIA HOLDINGS INC. (IQV) Form: 4 | Filed: 2026/02/11 Significance: Low
Insider: STAUB W RICHARD Title: President, Research & Development Solutions | Relationship: Officer
Transaction: • Type: Grant • Shares: 26,088 (Stock Appreciation Rights) • Price: $0.00 • Value: $0 • Owned After: 26,088 (Derivative Securities)
Key Insight: This is a routine equity award to an executive as part of a compensation package. The grant aligns the insider's interests with shareholders but has a negligible immediate market impact.
Market Context: The 26,088 derivative shares represent a potential dilution of only 0.015% of total shares outstanding for the $31.93B company.
Comprehensive Analysis
SEC Filing Analysis: IQVIA HOLDINGS INC. (IQV)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer received a routine grant of Stock Appreciation Rights (SARs) as part of their compensation package, representing a negligible potential dilution.
- Market Impact: Neutral. This is a standard executive compensation event with no immediate market-moving implications.
Company Information
| Field | Value |
|---|---|
| Company | IQVIA HOLDINGS INC. |
| Ticker Symbol | IQV |
| CIK | 0001478242 |
| Industry | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
Insider Information
| Field | Value |
|---|---|
| Name | STAUB W RICHARD |
| CIK | 0001181162 |
| Title/Position | President, Research & Development Solutions |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-02-09 |
| Transaction Code | A (Grant) |
| Security Type | Stock Appreciation Right |
| Shares Involved | 26,088 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 26,088 (Derivative Securities) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 26,088 |
| % of Shares Outstanding | 0.015% |
| Post-Transaction Ownership | 26,088 derivative shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value is $0, which is immaterial for a company with a $31.93 billion market capitalization.
- Dilution Impact: The grant represents a potential future dilution of 0.015% of shares outstanding, which is negligible and a common practice for executive compensation in large-cap companies.
- Transaction Significance: The transaction is classified as low significance due to its nature as a standard equity grant and its minimal impact relative to the company's market cap and shares outstanding.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to executives are routine and expected. They do not signal new information to the market and are not indicative of an insider's short-term outlook on the stock's performance.
Volume & Sentiment
- Expected Volume Impact: None. This is a non-market transaction.
- Sentiment Indicator: Neutral. The filing is informational and part of a standard compensation plan.
Additional Context
Transaction Notes
- Vesting Schedule: The Stock Appreciation Rights vest in three annual installments starting on February 9, 2027, aligning the executive's long-term interests with those of shareholders.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
